Puberty‐Promoting Treatment and Psychosocial Well‐Being in Boys With Constitutional Delay of Puberty: A Randomized Controlled Trial
Laura Kariola(Helsinki Children's Hospital), Matti Hero(University of Helsinki), Hanna Huopio(Tampere University Hospital), Olli Raitakari(University of Turku), Päivi J. Miettinen(University of Helsinki), Sirpa Tenhola(Kymenlaakson keskussairaala), Silja Kosola(Helsinki University Hospital), Tero Varimo(University of Helsinki), Taneli Raivio(University of Helsinki), Raimo Voutilainen(University of Eastern Finland), Jorma Toppari(University of Turku), Marko Elovainio(University of Helsinki), Mitja Lääperi(Helsinki University Hospital)
Cited by 2
Related Papers
Incidence, Phenotypic Features and Molecular Genetics of Kallmann Syndrome in Finland
|Orphanet Journal of Rare Diseases|2011|192
Gut microbiota develop towards an adult profile in a sex-specific manner during puberty
|Scientific Reports|2021|97
Treatment of gonadotropin deficiency during the first year of life: long-term observation and outcome in five boys
|Human Reproduction|2019|49
Precocious Puberty or Premature Thelarche: Analysis of a Large Patient Series in a Single Tertiary Center with Special Emphasis on 6- to 8-Year-Old Girls
|Frontiers in Endocrinology|2017|44
Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial
|The Lancet Child & Adolescent Health|2019|34